These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3736415)

  • 1. Plasma apolipoprotein CII levels in hypertriglyceridemia.
    Ishibashi S; Murase T; Takahashi K; Mori N; Kawakami M; Takaku F
    Metabolism; 1986 Aug; 35(8):781-5. PubMed ID: 3736415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitation of human apolipoprotein C-III and its subspecie by radioimmunoassay and analytical isoelectric focusing: abnormal plasma triglyceride-rich lipoprotein apolipoprotein C-III subspecie concentrations in hypertriglyceridemia.
    Kashyap ML; Srivastava LS; Hynd BA; Gartside PS; Perisutti G
    J Lipid Res; 1981 Jul; 22(5):800-10. PubMed ID: 7288286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radioimmunoassay of human apolipoprotein CII. A study in normal and hypertriglyceridemic subjects.
    Kashyap ML; Srivastava LS; Chen CY; Perisutti CG; Campbell M; Lutmer RF; Glueck CJ
    J Clin Invest; 1977 Jul; 60(1):171-80. PubMed ID: 194919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein AI and AII metabolism in patients with primary high-density lipoprotein deficiency associated with familial hypertriglyceridemia.
    Saku K; Gartside PS; Hynd BA; Mendoza SG; Kashyap ML
    Metabolism; 1985 Aug; 34(8):754-64. PubMed ID: 3927110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Composition and distribution of lipid and apolipoprotein in plasma lipoproteins of endogenous hypertriglyceridemia].
    Zhang L; Liu B
    Hua Xi Yi Ke Da Xue Xue Bao; 1992 Jun; 23(2):117-21. PubMed ID: 1452137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of apolipoprotein CII causes hypertriglyceridemia in transgenic mice.
    Shachter NS; Hayek T; Leff T; Smith JD; Rosenberg DW; Walsh A; Ramakrishnan R; Goldberg IJ; Ginsberg HN; Breslow JL
    J Clin Invest; 1994 Apr; 93(4):1683-90. PubMed ID: 8163669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Quantitation of human serum apolipoprotein CII by radial immunodiffusion assay].
    Fan P; Liu BW; Fu MD; Zhang RJ
    Hua Xi Yi Ke Da Xue Xue Bao; 1989 Dec; 20(4):352-5. PubMed ID: 2517121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein CII-Padova (Tyr37-->stop) as a cause of chylomicronaemia in an Italian kindred from Siculiana.
    Tuzgöl S; Bijvoet SM; Bruin T; Kastelein JJ; Hayden MR
    J Med Genet; 1994 Aug; 31(8):622-6. PubMed ID: 7815420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patients with nephrotic-range proteinuria have apolipoprotein C and E deficient VLDL1.
    Deighan CJ; Caslake MJ; McConnell M; Boulton-Jones JM; Packard CJ
    Kidney Int; 2000 Sep; 58(3):1238-46. PubMed ID: 10972686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein CII from rainbow trout (Oncorhynchus mykiss) is functionally active but structurally very different from mammalian apolipoprotein CII.
    Shen Y; Lindberg A; Olivecrona G
    Gene; 2000 Aug; 254(1-2):189-98. PubMed ID: 10974550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Capacity of high-density lipoprotein for donating apolipoproteins to fat particles in hypertriglyceridemia induced by fat infusion.
    Iriyama K; Tonouchi H; Azuma T; Suzuki H; Carpentier YA
    Nutrition; 1991; 7(5):355-7. PubMed ID: 1804473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial chylomicronemia caused by a novel type of mutation in the APOE-CI-CIV-CII gene cluster encompassing both the APOCII gene and the first APOCIV gene mutation: APOCII-CIV(Nijmegen).
    de Graaf J; Hoffer MJ; Stuyt PM; Frants RR; Stalenhoef AF
    Biochem Biophys Res Commun; 2000 Jul; 273(3):1084-7. PubMed ID: 10891375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of action of gemfibrozil on lipoprotein metabolism.
    Saku K; Gartside PS; Hynd BA; Kashyap ML
    J Clin Invest; 1985 May; 75(5):1702-12. PubMed ID: 3923042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis.
    Attman PO; Samuelsson OG; Moberly J; Johansson AC; Ljungman S; Weiss LG; Knight-Gibson C; Alaupovic P
    Kidney Int; 1999 Apr; 55(4):1536-42. PubMed ID: 10201020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The CII/CIII ratio of transferable apolipoprotein in primary and secondary hypertriglyceridemia.
    Erkelens DW; Mocking JA
    Clin Chim Acta; 1982 May; 121(1):59-65. PubMed ID: 7083594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E.
    Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
    Biochim Biophys Acta; 2000 Feb; 1484(1):29-40. PubMed ID: 10685028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Allelic variants of apolipoproteins B and CII genes in patients with ischemic heart disease and in healthy persons from the Moscow population].
    Pogoda TV; Nikonova AL; Kolosova TV; Liudvikova EK; Perova NV; Limborskaia SA
    Genetika; 1995 Jul; 31(7):1001-9. PubMed ID: 7590197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversible increase of the apo CII/apo CIII-1 ratio in the very low density lipoproteins after procetofen treatment in hypertriglyceridemic patients.
    Franceschini G; Sirtori M; Gianfranceschi G; Frosi T; Montanari G; Sirtori CR
    Artery; 1985; 12(6):363-81. PubMed ID: 4051756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of heparin-induced lipolysis on the distribution of apolipoprotein e among lipoprotein subclasses. Studies with patients deficient in hepatic triglyceride lipase and lipoprotein lipase.
    Rubinstein A; Gibson JC; Paterniti JR; Kakis G; Little A; Ginsberg HN; Brown WV
    J Clin Invest; 1985 Feb; 75(2):710-21. PubMed ID: 3973025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of slow-release bezafibrate on serum lipids, lipoproteins, apolipoproteins, and postheparin lipolytic activities in patients with type IV and type V hypertriglyceridemia.
    Saku K; Sasaki J; Arakawa K
    Clin Ther; 1989; 11(3):331-40. PubMed ID: 2743372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.